NeuroProof
    Skip navigation
    • Home
     
    Skip navigation
    • Services
    • Technology
    • Publications
    • Contact
    • About Us
    • News
     
    Screening for phenotypic activity patterns
     
    • Services
      • Disease Models
        • Alzheimer
        • Parkinson
        • Epilepsy
        • ALS model
        • Fragile X Syndrome
      • Cell viability and cytotoxicity
      • Target validation
      • Neuronal Maturation
      • Combination and Adjunctive Therapy
      • Prediction of side effects
      • Stem Cells
      • Data Analysis
    • Technology
      • Phenotypic Screening
      • Neuronal Cultures
        • Primary Cell Cultures
        • Neural Stem Cells
      • MEA Neurochip Recordings
      • Data Analysis
        • Spike Train Analysis
        • Pattern Recognition
        • Substance Database
      • Molecular Biology
    • Publications
      • Scientific Publications
      • Downloads
      • Image Gallery
      • Meetings
        • 2016
        • 2015
        • 2014
        • 2013
        • 2012
        • 2011
    • Contact
      • Contact Us
      • Directions
    • About Us
      • Company Profile
      • Management
      • Partner
      • Careers
    • News
      • News
        • 2015
        • Older
      • Subscribe to Newsletter
    Top

    © NeuroProof GmbH, Rostock, Germanymail: info@neuroproof.comphone: +49 381 54345-660

    Skip navigation
    • Imprint
    • Privacy Policy
    • Sitemap